Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
Resource Type
Article
Authors
Jones, David ; Boudes, Pol F ; Swain, Mark G ; Bowlus, Christopher L ; Galambos, Michael R ; Bacon, Bruce R ; Doerffel, Yvonne ; Gitlin, Norman ; Gordon, Stuart C ; Odin, Joseph A ; Sheridan, David ; Wörns, Markus-Alexander ; Clark, Virginia ; Corless, Linsey ; Hartmann, Heinz ; Jonas, Mark E ; Kremer, Andreas E ; Mells, George F ; Buggisch, Peter ; Freilich, Bradley L ; Levy, Cynthia ; Vierling, John M ; Bernstein, David E ; Hartleb, Marek ; Janczewska, Ewa ; Rochling, Fedja ; Shah, Hemant ; Shiffman, Mitchell L ; Smith, John H ; Choi, Yun-Jung ; Steinberg, Alexandra ; Varga, Monika ; Chera, Harinder ; Martin, Robert ; McWherter, Charles A ; Hirschfield, Gideon M
Source
In The Lancet Gastroenterology & Hepatology October 2017 2(10):716-726
Subject
Primary Research Articles
Language
ISSN
2468-1253